Latest papers

Rationalizing the activities of diverse cholecystokinin 2 receptor antagonists using molecular field points.

A case of concomitant polymorphism and spontaneous resolution: the tetragonal phase of 5-hydroxymethyl-7,7,N-trimethyl-6-oxabicyclo[3.2.1]octane-1-carboxamide.

A hydrogen-bonded chain of rings in 5-amino-1-(4-methoxybenzoyl)-3-methylpyrazole and a three-dimensional hydrogen-bonded framework in 5-amino-3-methyl-1-(2-nitrobenzoyl)pyrazole.

Alpha-amination of nitrogen heterocycles: ring-fused aminals.

Disposition and metabolism of [14C]brasofensine in rats, monkeys, and humans.

Two new metabolites from the mangrove endophytic fungus no. 2106.

cis-Jasmone induces accumulation of defence compounds in wheat, Triticum aestivum.

Diversity-oriented synthesis towards conceptually new highly modular aminal-pyrrolidine organocatalysts.

Sterically and polarity-controlled reactions of tBuLi with P=CH-NR heterocycles: novel heterocyclic P- and P,O-ligands and preliminary tests in transition-metal catalysis.

Structural diversity of bicyclic amino acids.

Modeling anti-Trypanosoma cruzi activity of N-oxide containing heterocycles.

The mechanism of TBD-catalyzed ring-opening polymerization of cyclic esters.

Synthetic entries to substituted bicyclic pyridones.

Chemical constituents from the aerial parts of Lippia nodiflora Linn.

Linear free energy relationships in C-N bond dissociations in molecular ions of 4-substituted N-(2-furylmethyl)anilines in the gas phase.

Steroid effects on intracellular degradation of insulin and crinophagy in isolated pancreatic islets.

Synthesis of novel functionalized 3-spiropyrrolizidine and 3-spiropyrrolidine oxindoles from Baylis-Hillman adducts of isatin and heteroaldehydes with azomethine ylides via [3+2]-cycloaddition.

Indole-derived arynes and their Diels-Alder reactivity with furans.

Synthesis of [3-(3-chloro-4-fluorophenyl)-2-oxo-3,4-dihydro-2H-2lambda5- benzo[e][1,3,2]oxazaphosphinin-2-yl]-(aryl/alkyl) methanols and their bioactivity on sugarcane smut.

The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure.